monkey buy at 16c

I've gone completely mad on pig. See-ya in the mid 20s IMO. Check ann.

Sydney - Tuesday - April 28: (RWE Aust Business News) - In
response to the recent press coverage and shareholder enquiries regarding
swine 'flu', Imugene (ASX:IMU) has provided updated information regarding
its swine influenza vaccine projects.
The Imugene laboratory has developed a suite of poultry vaccines
for potential use in chickens against H5, H7 and H9 strains of avian
influenza using the Fowl Adenovirus Vector.
The Porcine Adenovirus Vector is equally suitable for the
production of swine influenza vaccines for use in pigs.
Imugene's vaccine development program commenced in early 2008 and
has identified both H1N1 and H3N2 vaccines as potential vaccines for
development.
Swine influenza is a respiratory viral disease of pigs and
outbreaks occur throughout many parts of the world.
Vaccination against swine influenza is routine in many countries.
Imugene is to produce two vaccines, one each for the H1 and H3
strains.
The vaccines will take approximately a further 4-8 weeks to
complete the laboratory construction phase.
The swine influenza vaccines may then enter the product
development program if commercial parameters are satisfied and the market
deemed sufficiently large.
To date, Imugene has rated other pig diseases as higher
commercial priorities and there are already other swine influenza
vaccines available.
Accordingly, the Imugene swine influenza vaccines are
predominantly to expand the available range of vaccines against existing
and developing pig diseases of commercial significance.